to inconsistency and confusion in the literature.
INTRODUCTION
Pseudobulbar affect (PBA) is a neurological disorder characterized by involuntary, sudden, and frequent episodes of laughing and/or crying that are typically out of proportion or incongruent to the underlying emotional state [1] [2] [3] [4] . Although the etiology of PBA is not completely understood, it is strongly associated with neurological disease or injury that affects the frontal lobes and descending pathways to the brainstem, basis pontis, and cerebellum, and its symptoms appear to be similar across different patient populations [1] [2] [3] . PBA has been reported secondary to a wide variety of neurological conditions; available prevalence data suggest that neurological conditions commonly associated with PBA include Alzheimer's disease (AD) and other dementias, amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), Parkinson's disease (PD), stroke, and traumatic brain injury (TBI) [2, 3, 5] .
Partly owing to different preferences across physician specialties, a variety of terms have been used to describe syndromes of inappropriate laughing and/or crying, and this has contributed inclusion in recent PBA clinical trials [17] [18] [19] 
Survey Sample
Survey participants were recruited in two waves.
To recruit the PBA group, invitations were first sent to 857 members of the Harris Panel Online (HPOL) sample, who had voluntarily agreed to participate in various HI online research surveys, had participated in the previous PBA prevalence survey, and had scored 13 or more on the CNS-LS in that survey, suggestive of PBA. To complete recruitment of the PBA group and to recruit the controls, invitations were then sent to a nationally representative sample of more than 6 million US adults (aged 18 years and over), registered in the HPOL, in a similar fashion to the recruitment procedure for the previous PBA prevalence survey [5] . At the time of recruitment, the HPOL included approximately 1.5 million individuals who had been screened by HI by means of a checklist for the presence of chronic illnesses. HPOL panel members previously identified by HI as either having AD, ALS, MS, PD, and stroke or being primary, nonpaid caregivers for a household member with one of these conditions were sent online invitations to participate in a survey about their "thoughts on and experiences with some important healthcare-related topics" [5] .
To enhance the representativeness of the total sample, invitations were also sent to a randomly selected national sample from the general HPOL.
Recruitment quotas were set for each underlying condition in order to have a large enough sample of each disease group for analysis.
The HI chronic illness screener instrument did not include patients with TBI [20] . To identify and recruit patients with TBI, survey invitations were
The authors have recently published the results of a survey conducted using the CNS-LS to estimate the prevalence of PBA in the USA across six commonly associated underlying conditions: AD and other dementias, ALS, MS, PD, stroke, and TBI [5] . Adopting a conservative CNS-LS cutoff score of 21 or greater yielded an overall prevalence of 9.4%, which translated to 500,000 to 2 million individuals in the USA with PBA. With a lower CNS-LS threshold of 13 or greater, which helps identify less severely affected patients with a reasonable sensitivity and specificity, the prevalence was even higher cases [20] .
MATERIALS AND METHODS
The survey invitations were identical for all invitees, i.e., the invitations that were sent to HPOL members who had participated in the previous prevalence survey did not reference that survey or the participants' previous participation. Invitations included a unique log-in name and password to confirm that the person responding was the selected participant.
Selection of the ultimate sample for each primary condition was designed to include a mix of responses from patients and caregivers, with target proportions of two-thirds patients and one-third caregivers in both the PBA and control groups. Numeric quotas were assigned to each disease group and proportion of respondents with PBA and without PBA within each disease group. The online program assigned respondents into each quota group based on survey logic.
Identification of Patients with PBA and

Matched Controls
Eligible respondents (those confirmed to be patients or primary, nonpaid caregivers for patients with one of the six designated conditions) completed an online CNS-LS [15, 16] .
Patients and caregivers were asked the same screening questions, with caregivers answering based on their observations of the patient.
Respondents with a CNS-LS score of 13 or greater were assigned to the PBA group; respondents with a CNS-LS score less than 13 were assigned to the control group. The control (non-PBA) participants were included to discern the burden of PBA incremental to other problems stemming from the primary neurological disease. Once the survey program assigned each respondent to either the PBA or non-PBA group, respondents continued through the remainder of the survey.
Burden of Illness Measures
In order to measure various aspects of burden of illness in PBA group respondents and controls, (1, "no occurrence" or "occurrence, but no distress;" 2, "mild distress;" 3, "moderate distress;" or 4, "severe distress"). The CES-D10 scale is a screening test for depression with each item scored from 0 to 3 (scoring range of 0-30), and with a validated cutoff score of 10 or greater for clinically meaningful depressive symptoms [24] .
VAS for QOL and QOR asked patients to indicate "the degree to which uncontrollable laughter, tearfulness, or anger" had affected the overall QOL and the overall QOR during the past week, by making a mark on a horizontal line with anchors of "0, not at all" on the left and "100, continuously" on the right.
In addition to the above scales, specific questions were asked to assess the emotional state of the patients over the past week, the frequency, burdensomeness, and emotional impact of involuntary laughing and/or crying episodes, and the degree to which these episodes disrupted specific life activities. For example, respondents were asked the degree to which episodes of involuntary laughter or crying interfered with activities such as spending time Only the PBA group patients and caregivers (no controls) answered the customized questions related to the frequency, burdensomeness, and impact of PBA episodes, with caregivers answering these questions on behalf of their patients. Table 1 provides a summary of the scales and respondents.
Control for Underlying Disease Severity
In order to account for the impact of potential differences in underlying disease severity on results, respondents were asked to self-rate 
Demographic Weighting
To adjust for demographic differences between the PBA and control groups, weighting multipliers were applied to PBA and control respondent data by disease group to make them more similar to each other in terms of age and gender (when sample size was sufficiently large)
to minimize variation in responses that might be attributable to these demographic characteristics.
This was not possible for the AD and ALS disease groups. The number of AD and other dementias patient respondents was too small to apply an adjustment because, due to the disabling nature of the disease, 90% of the AD and other dementias respondents were caregivers.
The number of ALS patient respondents was also too small to apply an adjustment due to difficulties with recruitment stemming from the low prevalence of this condition in the overall population. All "unweighted" respondents were given a demographic weight of 1.0.
To adjust for the relative proportions of the six underlying conditions within the total US population (including the estimated prevalence of PBA within each condition), and thus increase generalizability to the total US patient population, additional post weights were applied to all outcomes reported for the total study population across PBA/control and disease subgroups ( Table 2 ) [5] .
Margin of Sampling Error
In a random probability sample of respondents, study results are subject to a margin of sampling error, which is calculated using the size of the sample. Although the sample in this study was not a random probability sample in its for the non-PBA group, the margin of error was 30.2% for the ALS group and ranged from ±8% to 9.6% for the others.
Significance Tests
Two group t tests were conducted to test for mean differences in study measures between the PBA and control groups and within each disease state. All significance testing was performed at the 95% confidence interval, two tailed. These tests were performed after all other weighting (as described above) was applied to the data.
The severity weights were used to validate the statistical significance of differences, and all
reported P values in the article reflect adjustment for disease severity; however, numerical results reported reflect only the demographic weighting as described above.
RESULTS
Study Population
Of 857 patients/caregivers of patients with a CNS-LS score of 13 or greater from the initial HPOL prevalence survey [5] who were recontacted in the first wave of recruitment for this survey, 599 (70%) responded, of whom (Table 3 ). In the PBA group, 66.4% were patients and 33.6% were caregivers, and in the control group, 63.3% were patients and 36.7% were caregivers (Table 3) .
Recruitment did not meet the quota for the ALS group. The goal of achieving proportions of two-thirds patients and one-third caregivers was achieved for most diseases in the PBA group, but not for the control group, most notably for ALS, which comprised only 11 controls including four patients (36%) and seven caregivers (64%), and AD and other dementias, which comprised 8% patients and 92% caregivers (Table 3) .
Demographic characteristics are provided in While the majority of respondents assessed the severity of their/their patients' primary neurological disease as mild or moderate (Table 4) , significantly more PBA respondents in the PD (13% PBA vs. 3% controls) and stroke (18% PBA vs. 7% controls) groups rated their/their patients' condition as severe (P < 0.05 for both).
On the validated disease-specific severity scales, respectively, for the non-PBA controls (P < 0.05) (Fig. 1) . The between-group differences were generally larger for the mental health domain items than for the physical health domain items, 
The WPAI Questionnaire
The PBA group patients and caregivers were less likely to be employed for pay, and experienced greater work and activity impairment than the control group patients and caregivers (Table 5 ). Among patients, significant differences over the previous 7 days were observed between the PBA was significantly higher in the PBA versus the control group patients in the MS, PD, stroke, and TBI disease groups (P < 0.05). While rates of depressive symptoms were also higher among the PBA group patients with AD and ALS than among controls with the same diseases, the differences were less pronounced and the disease subgroups were too small for these differences to reach statistical significance. (Table 6) .
Depression: Caregiver Respondents
Depressive symptoms (CES-D10 scale score ≥10)
were also present in most caregivers and occurred with similar overall frequency in the PBA and control groups (73% and 71%, respectively).
Within disease subgroups, significantly more control group caregivers of patients with AD and other dementias experienced depressive symptoms (79%) compared with their PBA group counterparts (56%), whereas significantly more PBA group caregivers for patients with PD (68%) and TBI (91%) experienced depressive symptoms compared with controls (33% and 43%, respectively; P < 0.05 for all).
Screen for Caregiver Burden
Mean total scores on the SCB suggested that the overall burden of caring for patients in the PBA group was slightly but significantly higher than for the control group. Both the objective (prevalence) and subjective (distress) scores were higher among caregivers in the PBA group (13.7 and 41.5, respectively; P = 0.05) compared with the control group (10.2 and 37.6, respectively; P = 0.05).
Impact on Feelings and Activities
Significantly higher percentages of patients (including caregivers rating as patient proxies) in the PBA group than in the non-PBA control group reported negative emotional feelings in The first number in each cell is the F value, followed by the probability of larger F value, and whether the impact of the factor SF-36 item score is significant (yes/no) c Assesses whether PBA group assignment had a significant impact (main effect) on SF-36 score d Assesses whether the presence of depression (CES-D10 >10) had a significant impact (main effect) on SF-36 score e Indicates whether there is significant interacting effect of depression on the effect of PBA group assignment f Indicates whether assignment to the PBA group has an effect to increase or reduce the SF-36 item score. If an interaction is present, the statement in parentheses indicates the effect of the interaction, i.e., whether the presence of depression augments or reduces the impact of PBA group assignment on the SF-36 item score (Fig. 3 ).
In addition, from 9.0% to 24.4% of these respondents said that involuntary episodes of laughing and/or crying contributed "a great deal" to or "were the main cause" of distressing life situations such as moving to a nursing home or supervised living (9%), quitting or being fired from a job (16%), getting a divorce or ending a (Fig. 4) . [14] ; while the other, which also included patients with other movement disorders (n = 387 PD patients; n = 332 other movement disorders), did show a significant association of depression and PBA in the total study population [10] . Both of these studies also found greater functional impairment in the unified Parkinson's disease rating scale ADL section in patients with PBA (IEED); however, this association was considered more likely to be attributable to greater duration or severity of illness in these patients [10, 14] . with those who did not have these symptoms [9] .
Conversely, a matched case-control study (n = 24) of neurobehavioral correlates of pathological laughing and crying in patients with MS did not show differences between groups in the social dysfunction component of the general health questionnaire; however, patients in this sample were said to be severely disabled, and general health questionnaire social dysfunction items were commonly endorsed by both case and control groups in the study [32] . As noted above, a positive association between CNS-LS scores and depressive symptoms has been observed in patients with ALS and PD [11, 15, 41] , and the prevalence of depression was also significantly higher in PBA group patients (87%) than controls (56%) in this study. 
